Schneller F - Search Results

1

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.

von Bubnoff N, Schneller F, Peschel C, Duyster J. von Bubnoff N, et al. Among authors: schneller f. Lancet. 2002 Feb 9;359(9305):487-91. doi: 10.1016/S0140-6736(02)07679-1. Lancet. 2002. PMID: 11853795

2

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.

Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C, Decker T. Ringshausen I, et al. Among authors: schneller f. Blood. 2002 Nov 15;100(10):3741-8. doi: 10.1182/blood-2002-02-0539. Epub 2002 Jul 12. Blood. 2002. PMID: 12393602 Free article.

3

Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target.

Decker T, Hipp S, Hahntow I, Schneller F, Peschel C. Decker T, et al. Among authors: schneller f. Br J Haematol. 2004 Apr;125(2):141-8. doi: 10.1111/j.1365-2141.2004.04901.x. Br J Haematol. 2004. PMID: 15059135 Free article.

4

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.

Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C. Decker T, et al. Among authors: schneller f. Leukemia. 2002 Mar;16(3):327-34. doi: 10.1038/sj.leu.2402389. Leukemia. 2002. PMID: 11896535

5

Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.

Hahntow IN, Schneller F, Oelsner M, Weick K, Ringshausen I, Fend F, Peschel C, Decker T. Hahntow IN, et al. Among authors: schneller f. Leukemia. 2004 Apr;18(4):747-55. doi: 10.1038/sj.leu.2403295. Leukemia. 2004. PMID: 14973497

6

Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways.

Bogner C, Schneller F, Hipp S, Ringshausen I, Peschel C, Decker T. Bogner C, et al. Among authors: schneller f. Exp Hematol. 2003 Mar;31(3):218-25. doi: 10.1016/s0301-472x(02)01076-7. Exp Hematol. 2003. PMID: 12644019 Free article.

7

Biotherapy of chronic myelogenous leukemia.

Aulitzky WE, Peschel C, Schneller F, Huber C. Aulitzky WE, et al. Among authors: schneller f. Ann Hematol. 1995 Mar;70(3):113-20. doi: 10.1007/BF01682030. Ann Hematol. 1995. PMID: 7718640 Review.

8

Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.

Aulitzky WE, Neubauer A, Kolbe K, Schneller F, Busemann C, Schleiermacher E, Peschel C, Siegert W, Huber C, Huhn D. Aulitzky WE, et al. Among authors: schneller f. Bone Marrow Transplant. 1996 May;17 Suppl 3:S67-9. Bone Marrow Transplant. 1996. PMID: 8769707 Clinical Trial.

9

Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.

von Bubnoff N, Sandherr M, Schneller F, Peschel C. von Bubnoff N, et al. Among authors: schneller f. Am J Clin Oncol. 2000 Feb;23(1):74-7. doi: 10.1097/00000421-200002000-00021. Am J Clin Oncol. 2000. PMID: 10683084

10

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.

Decker T, Hipp S, Ringshausen I, Bogner C, Oelsner M, Schneller F, Peschel C. Decker T, et al. Among authors: schneller f. Blood. 2003 Jan 1;101(1):278-85. doi: 10.1182/blood-2002-01-0189. Epub 2002 Aug 29. Blood. 2003. PMID: 12393642 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters